| Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis C Tur, O Goodkin, DR Altmann, TM Jenkins, K Miszkiel, A Mirigliani, C Fini, ... Brain 139 (3), 816-828, 2016 | 87 | 2016 |
| Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review HG Pemberton, LAM Zaki, O Goodkin, RK Das, RME Steketee, F Barkhof, ... Neuroradiology 63 (11), 1773-1789, 2021 | 52 | 2021 |
| Cortical involvement determines impairment 30 years after a clinically isolated syndrome L Haider, F Prados, K Chung, O Goodkin, B Kanber, C Sudre, ... Brain 144 (5), 1384-1395, 2021 | 36 | 2021 |
| The quantitative neuroradiology initiative framework: application to dementia O Goodkin, H Pemberton, SB Vos, F Prados, CH Sudre, J Moggridge, ... The British journal of radiology 92 (1101), 20190365, 2019 | 32 | 2019 |
| Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence Z Mendelsohn, HG Pemberton, J Gray, O Goodkin, FP Carrasco, ... Neuroradiology 65 (1), 5-24, 2023 | 28 | 2023 |
| Hippocampal profiling: localized magnetic resonance imaging volumetry and T2 relaxometry for hippocampal sclerosis SB Vos, GP Winston, O Goodkin, HG Pemberton, F Barkhof, F Prados, ... Epilepsia 61 (2), 297-309, 2020 | 28 | 2020 |
| Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study HG Pemberton, O Goodkin, F Prados, RK Das, SB Vos, J Moggridge, ... European Radiology 31, 5312-5323, 2021 | 27 | 2021 |
| Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis O Goodkin, HG Pemberton, SB Vos, F Prados, RK Das, J Moggridge, ... European Radiology 31, 34-44, 2021 | 13 | 2021 |
| FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis O Goodkin, F Prados, SB Vos, H Pemberton, S Collorone, MHJ Hagens, ... NeuroImage: Clinical 29, 102542, 2021 | 10 | 2021 |
| Predicting cognitive decline in older adults using baseline metrics of AD pathologies, cerebrovascular disease, and neurodegeneration L Prosser, A Macdougall, CH Sudre, EN Manning, IB Malone, P Walsh, ... Neurology 100 (8), e834-e845, 2023 | 7 | 2023 |
| Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative CM Fiford, CH Sudre, AL Young, A Macdougall, J Nicholas, EN Manning, ... Brain communications 3 (4), fcab226, 2021 | 6 | 2021 |
| Multi-class glioma segmentation on real-world data with missing MRI sequences: Comparison of three deep learning algorithms HG Pemberton, J Wu, I Kommers, DMJ Müller, Y Hu, O Goodkin, SB Vos, ... Scientific reports 13 (1), 18911, 2023 | 4 | 2023 |
| Comparing clinical and radiological effectiveness of disease modifying treatments in the real-world M Moccia, S Al-Araji, L Zhang, O Abdel-Mannan, A Aojula, A Bianchi, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 10-11, 2022 | 2 | 2022 |
| Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndrome AR Gafson, O Goodkin, R Begent Case Reports 2010, bcr0420102869, 2010 | 1 | 2010 |
| Assessing outcomes of disease modifying therapies in late onset relapsing remitting MS patients in a real-world cohort S Al-Araji, M Moccia, A Jha, L Zhang, A Eshaghi, B Kanber, A Bianchi, ... MULTIPLE SCLEROSIS JOURNAL 29, 51-52, 2023 | | 2023 |
| Building automated MS quantitative reports using only FLAIR images Z Mendelsohn, F Prados, O Goodkin, G Pontillo, W Hamed, J Colman, ... MULTIPLE SCLEROSIS JOURNAL 29, 539-540, 2023 | | 2023 |
| Real-world comparison of high efficacy versus low/moderate efficacy DMTs in treatment naive relapsing-remitting multiple sclerosis patients using propensity score matching S Al-Araji, M Moccia, A Jha, L Zhang, A Eshaghi, B Kanber, A Bianchi, ... MULTIPLE SCLEROSIS JOURNAL 29, 623-625, 2023 | | 2023 |
| Age matters: clinical characteristics nd short-term treatment outcomes in late-onset multiple sclerosis S Collorone, S Al-Araji, M Moccia, A Jha, L Zhang, A Eshaghi, B Kanber, ... MULTIPLE SCLEROSIS JOURNAL 29, 605-606, 2023 | | 2023 |
| Spinal cord atrophy in patients on low/moderate and high-efficacy disease modifying treatments: 18-month real-world cohort M Moccia, W Hamed, F Prados, G Pontillo, S Al-Araji, A Aojula, A Bianchi, ... MULTIPLE SCLEROSIS JOURNAL 29, 365-366, 2023 | | 2023 |
| Commercial automated MRI reporting tools in multiple sclerosis: a systematic review of the evidence Z Mendelsohn, H Pemberton, J Gray, O Goodkin, F Prados Carrasco, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 554-555, 2022 | | 2022 |
